JP2024540322A5 - - Google Patents
Info
- Publication number
- JP2024540322A5 JP2024540322A5 JP2024526682A JP2024526682A JP2024540322A5 JP 2024540322 A5 JP2024540322 A5 JP 2024540322A5 JP 2024526682 A JP2024526682 A JP 2024526682A JP 2024526682 A JP2024526682 A JP 2024526682A JP 2024540322 A5 JP2024540322 A5 JP 2024540322A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- cell epitopes
- human
- acid sequence
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163275015P | 2021-11-03 | 2021-11-03 | |
| US63/275,015 | 2021-11-03 | ||
| US202263377087P | 2022-09-26 | 2022-09-26 | |
| US63/377,087 | 2022-09-26 | ||
| PCT/EP2022/080679 WO2023079001A1 (en) | 2021-11-03 | 2022-11-03 | Immunogenic constructs and vaccines for use in the prophylactic and therapeutic treatment of diseases caused by sars-cov-2 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024540322A JP2024540322A (ja) | 2024-10-31 |
| JP2024540322A5 true JP2024540322A5 (https=) | 2025-11-11 |
Family
ID=84365420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024526682A Pending JP2024540322A (ja) | 2021-11-03 | 2022-11-03 | ＳＡＲＳ－ＣｏＶ－２によって引き起こされる疾患の予防及び処置に使用するための免疫原性構築物及びワクチン |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250049910A1 (https=) |
| EP (1) | EP4426344A1 (https=) |
| JP (1) | JP2024540322A (https=) |
| KR (1) | KR20240110821A (https=) |
| AU (1) | AU2022381515A1 (https=) |
| CA (1) | CA3235174A1 (https=) |
| IL (1) | IL312539A (https=) |
| MX (1) | MX2024005408A (https=) |
| WO (1) | WO2023079001A1 (https=) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2531204T3 (es) | 2003-02-25 | 2015-03-11 | Vaccibody As | Anticuerpo modificado |
| JP2013532971A (ja) | 2010-06-25 | 2013-08-22 | バッシボディ アクスイェ セルスカプ | ホモ二量体タンパク質コンストラクト |
| BR112014015016B1 (pt) | 2011-12-21 | 2023-10-03 | Nykode Therapeutics ASA | Proteína homodimérica de duas cadeias de aminoácidos idênticas,cadeia de aminoácido, molécula de ácido nucléico, composição farmacêutica,célula hospedeira, método de preparação de uma proteína homodimérica, método de preparação de uma vacina e vacina |
| IL260030B2 (en) | 2016-01-08 | 2025-12-01 | Nykode Therapeutics ASA | Therapeutic anticancer neoepitope vaccine |
| WO2020176797A1 (en) | 2019-02-27 | 2020-09-03 | Nektar Therapeutics | Immunotherapeutic combination for treating cancer |
| TWI818236B (zh) * | 2020-02-19 | 2023-10-11 | 美商聯合生物醫學公司 | 用於檢測、預防和治療新型冠狀病毒(covid-19)疾病的設計胜肽及蛋白質 |
| US20230218741A1 (en) * | 2020-03-31 | 2023-07-13 | The Children's Hospital Of Philadelphia | Sars-cov-2 vaccines for population-scale immunity |
-
2022
- 2022-11-03 WO PCT/EP2022/080679 patent/WO2023079001A1/en not_active Ceased
- 2022-11-03 JP JP2024526682A patent/JP2024540322A/ja active Pending
- 2022-11-03 CA CA3235174A patent/CA3235174A1/en active Pending
- 2022-11-03 KR KR1020247018623A patent/KR20240110821A/ko active Pending
- 2022-11-03 IL IL312539A patent/IL312539A/en unknown
- 2022-11-03 US US18/706,648 patent/US20250049910A1/en active Pending
- 2022-11-03 AU AU2022381515A patent/AU2022381515A1/en active Pending
- 2022-11-03 EP EP22813933.3A patent/EP4426344A1/en active Pending
- 2022-11-03 MX MX2024005408A patent/MX2024005408A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Han et al. | IL-15: IL-15 receptor alpha superagonist complex: high-level co-expression in recombinant mammalian cells, purification and characterization | |
| EP3998077B1 (en) | Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo | |
| JP2022017499A (ja) | 治療用抗癌ネオエピトープワクチン | |
| JP2019123719A (ja) | インターロイキン−１０を疾病及び疾患の治療に用いる方法 | |
| JP2013513377A5 (https=) | ||
| RU2012129208A (ru) | Конъюгаты и композиции для иммунотерапии и противоопухолевого лечения | |
| JP2022541657A5 (https=) | ||
| RU2677799C2 (ru) | Модифицированные суперспиральные белки с улучшенными свойствами | |
| WO2004026897A1 (ja) | Ｗｔ１置換型ペプチド | |
| JP2023528207A5 (https=) | ||
| JP2023522588A5 (https=) | ||
| CA2730686A1 (en) | Anti-amyloid immunogenic compositions, methods and uses | |
| WO2011101332A1 (en) | Compositions based on the fibronectin extracellular domain a for the treatment of melanoma | |
| IL292358A (en) | specific binding molecules | |
| JP2024516613A5 (https=) | ||
| JP2012503976A (ja) | インターロイキン−１５活性のペプチドアンタゴニスト | |
| ES2217199T3 (es) | Mutantes de quimioquinas en el tratamiento de la esclerosis multiple. | |
| KR101101004B1 (ko) | 신규한 펩티드 및 그들의 치료 용도 | |
| JP4299777B2 (ja) | 免疫応答を誘導するための方法および組成物 | |
| CN113226348B (zh) | 免疫治疗il-6失调疾病的il-6的肽免疫原及其制剂 | |
| WO2022141771A1 (zh) | 一种长效化白介素15融合蛋白及其制备方法和应用 | |
| JP2024540322A5 (https=) | ||
| TWI905155B (zh) | 包含 il-2蛋白及cd80蛋白片段或其變異體的融合蛋白及其用途 | |
| US5587457A (en) | Neutrophil stimulating peptides | |
| CN113874393A (zh) | 对hbv包膜蛋白具有特异性的结合分子 |